Russell Investments Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-743
| Closed | -$1.03K | – | 3809 |
|
2024
Q4 | $1.03K | Buy |
+743
| New | +$1.03K | ﹤0.01% | 3521 |
|
2024
Q3 | – | Sell |
-72,955
| Closed | -$126K | – | 3707 |
|
2024
Q2 | $126K | Buy |
+72,955
| New | +$126K | ﹤0.01% | 2578 |
|
2024
Q1 | – | Sell |
-73,102
| Closed | -$243K | – | 3315 |
|
2023
Q4 | $243K | Buy |
+73,102
| New | +$243K | ﹤0.01% | 2393 |
|
2023
Q3 | – | Sell |
-1,155
| Closed | -$4.93K | – | 3540 |
|
2023
Q2 | $4.93K | Sell |
1,155
-86,695
| -99% | -$370K | ﹤0.01% | 3112 |
|
2023
Q1 | $601K | Sell |
87,850
-2,644
| -3% | -$18.1K | ﹤0.01% | 2188 |
|
2022
Q4 | $717K | Buy |
90,494
+8,141
| +10% | +$64.5K | ﹤0.01% | 2138 |
|
2022
Q3 | $789K | Sell |
82,353
-25,689
| -24% | -$246K | ﹤0.01% | 2038 |
|
2022
Q2 | $781K | Buy |
108,042
+86,542
| +403% | +$626K | ﹤0.01% | 2068 |
|
2022
Q1 | $277K | Buy |
+21,500
| New | +$277K | ﹤0.01% | 2390 |
|
2021
Q2 | – | Sell |
-66,535
| Closed | -$971K | – | 3217 |
|
2021
Q1 | $971K | Sell |
66,535
-24,316
| -27% | -$355K | ﹤0.01% | 2256 |
|
2020
Q4 | $1.58M | Buy |
90,851
+25,169
| +38% | +$437K | ﹤0.01% | 1881 |
|
2020
Q3 | $1.2M | Buy |
65,682
+14,393
| +28% | +$264K | ﹤0.01% | 1978 |
|
2020
Q2 | $915K | Sell |
51,289
-10,467
| -17% | -$187K | ﹤0.01% | 2107 |
|
2020
Q1 | $1M | Buy |
61,756
+24,956
| +68% | +$405K | ﹤0.01% | 1839 |
|
2019
Q4 | $662K | Sell |
36,800
-63,204
| -63% | -$1.14M | ﹤0.01% | 2296 |
|
2019
Q3 | $2.03M | Buy |
+100,004
| New | +$2.03M | ﹤0.01% | 1679 |
|
2017
Q3 | – | Sell |
-5,888
| Closed | -$84K | – | 2950 |
|
2017
Q2 | $84K | Sell |
5,888
-19,839
| -77% | -$283K | ﹤0.01% | 2828 |
|
2017
Q1 | $545K | Sell |
25,727
-11,390
| -31% | -$241K | ﹤0.01% | 2391 |
|
2016
Q4 | $1.05M | Buy |
+37,117
| New | +$1.05M | ﹤0.01% | 2150 |
|